AIBS is pleased to announce that Shyla Cooks and Karl Palmquist have been selected as the 2021 AIBS Emerging Public Policy Leadership Award (EPPLA) recipients. The EPPLA recognizes graduate students in the biological sciences who are demonstrating an interest and aptitude for working at the intersection of science and policy.

Lawmakers are now working to craft a $1.9 trillion COVID-19 pandemic relief package—the blueprint for which was adopted by both chambers of Congress on February 5, 2021 in the form of a budget resolution.

AIBS has endorsed an action plan developed by the Science and Technology Action Committee calling for doubling the federal expenditure for research and development and STEM education relative to GDP over the next five years.

AIBS has endorsed a petition expressing support for scientific research stations and their educational programming that have been adversely impacted by financial concerns as a result of the COVID-19 pandemic.

A group of more than 90 scientific and medical stakeholder organizations, including AIBS, have called on President Joe Biden to withdraw a January 13, 2021 proposed rule on extramural research involving human fetal tissue (HFT).

The American Institute of Biological Sciences (AIBS) joined 45 scientific, academic, and medical stakeholder groups in expressing support for legislation aimed at scaling up efforts to track and respond to coronavirus variants in the United States.

On January 27, 2021, the Biden Administration issued a memorandum ordering a government-wide review of the effectiveness of existing scientific integrity policies.

Soon after taking office on January 20, 2021, President Joe Biden signed a myriad of Executive Orders pertaining to the ongoing pandemic, the climate crisis, and other science-related issues.

Details about who will serve on key congressional committees with jurisdiction over scientific research and education are emerging.

On January 14, 2021, President Trump issued a National Security Presidential Memorandum offering guidance to federal agencies, universities, and researchers on how to protect the U.S. research enterprise from foreign interference while still allowing for open and collaborative international science.